By Viviane Trojan
2 de July de 2024
Life Sciences’ Brazil Global Guide 2024 is now available
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys at law Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2024 guide for Brazil, that outlines the regulatory framework for pharmaceuticals and medical devices, detailing the legislation, regulatory bodies and procedures for securing approvals and handling appeals. It covers categorisation, clinical trials, marketing authorizations and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, the stringent requirements for biologics and the procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations and measures against counterfeit products.
For more details, click here.
Share:
Last by Viviane Trojan
19 de August de 2026
Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a … Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
5 de August de 2026
Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
We have been closely monitoring the progress of Bill No. 2,210/2022, which proposes significant amendments to the Brazilian Industrial Property Law, Law … Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System
8 de July de 2026
SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
ABSTRACT: The increasing judicialization of disputes involving Standard Essential Patents (SEPs) has shifted the focus of legal debate beyond the mere assessment … SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements